SCHEMBL4257593

SCHEMBL4257593

CCOC(=O)c1ccc(Oc2cccc(OC)c2)nc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 1/20 0.56
ALDH1A1 P00352 4/20 0.54
KDM4E B2RXH2 2/20 0.54
MEN1 O00255 1/20 0.54
BRCA1 P38398 1/20 0.54
HBB P68871 1/20 0.54
KMT2A Q03164 1/20 0.54
HSD17B10 Q99714 1/20 0.54
EGFR P00533 1/20 0.52
ERBB3 P21860 1/20 0.52
MAPT P10636 4/20 0.51
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
F10 P00742 2/20 0.50
F2 P00734 1/20 0.50
TDP1 Q9NUW8 3/20 0.48
L3MBTL1 Q9Y468 3/20 0.48
MAPK1 P28482 3/20 0.48
GAA P10253 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4252330 0.86 KDM4E (0.56) PDE4BALDH1A1KDM4EMAPTRAB9A
SCHEMBL2255952 0.85 PDE4B (0.56) PDE4BKDM4EMEN1KMT2AMAPT
SCHEMBL4250555 0.85 PDE4B (0.54) PDE4BALDH1A1KDM4EMEN1KMT2A
SCHEMBL4254797 0.83 KDM4E (0.61) ALDH1A1KDM4EMEN1BRCA1HBB
SCHEMBL4253237 0.82 MEN1 (0.59) ALDH1A1KDM4EMEN1BRCA1HBB
SCHEMBL5529678 0.82 KDM4E (0.63) ALDH1A1KDM4EMEN1BRCA1HBB
SCHEMBL17869086 0.82 TSHR (0.55) PDE4BALDH1A1KDM4EMEN1KMT2A
SCHEMBL4257740 0.81 MAPT (0.59) PDE4BALDH1A1KDM4EMEN1KMT2A
SCHEMBL10972399 0.81 NNMT (0.60) PDE4BKDM4EMEN1KMT2AMAPT
SCHEMBL19362950 0.80 PDE4B (0.58) PDE4BKDM4EKMT2AMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
EP-1710233-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE Kissei Pharmaceutical Co., Ltd. (JP) 2006-10-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE ADORA2A, ADORA2B, HTR1F PDE4B 962/4885ALDH1A1 559/4885KDM4E 4227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.